| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
111 Inc (NASDAQ: YI)
YI Technical Analysis
4
| As on 15th Sep 2025 YI STOCK Price closed @ 5.92 and we RECOMMEND Buy for LONG-TERM with Stoploss of 1.59 & Strong Buy for SHORT-TERM with Stoploss of 1.15 we also expect STOCK to react on Following IMPORTANT LEVELS. |
YISTOCK Price
| Open | 6.30 | Change | Price | % |
| High | 6.37 | 1 Day | 0.00 | 0.00 |
| Low | 5.80 | 1 Week | 0.41 | 7.44 |
| Close | 5.92 | 1 Month | -1.00 | -14.45 |
| Volume | 72878 | 1 Year | 4.70 | 385.25 |
| 52 Week High 11.00 | 52 Week Low 0.43 | ||||
NASDAQ USA Most Active Stocks
| AMRS | 0.14 | 100.00% |
| WBA | 11.98 | 0.50% |
| OPEN | 9.49 | 4.63% |
| BITF | 2.48 | 11.21% |
| TSLA | 410.04 | 3.56% |
| OPI | 0.88 | 60.00% |
| NVDA | 177.75 | -0.04% |
| CHEK | 2.12 | 182.67% |
| LMDX | 0.02 | 0.00% |
| AKTS | 0.04 | 0.00% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| YI Daily Charts |
YI Intraday Charts |
Whats New @ Bazaartrend |
YI Free Analysis |
|
|
YI Important Levels Intraday
| RESISTANCE | 7.02 |
| RESISTANCE | 6.67 |
| RESISTANCE | 6.45 |
| RESISTANCE | 6.23 |
| SUPPORT | 5.61 |
| SUPPORT | 5.39 |
| SUPPORT | 5.17 |
| SUPPORT | 4.82 |
YI Forecast September 2025
| 4th UP Forecast | 6.77 |
| 3rd UP Forecast | 6.5 |
| 2nd UP Forecast | 6.33 |
| 1st UP Forecast | 6.16 |
| 1st DOWN Forecast | 5.68 |
| 2nd DOWN Forecast | 5.51 |
| 3rd DOWN Forecast | 5.34 |
| 4th DOWN Forecast | 5.07 |
YI Weekly Forecast
| 4th UP Forecast | 6.50 |
| 3rd UP Forecast | 6.31 |
| 2nd UP Forecast | 6.20 |
| 1st UP Forecast | 6.08 |
| 1st DOWN Forecast | 5.76 |
| 2nd DOWN Forecast | 5.64 |
| 3rd DOWN Forecast | 5.53 |
| 4th DOWN Forecast | 5.34 |
YI Forecast2025
| 4th UP Forecast | 27 |
| 3rd UP Forecast | 20.24 |
| 2nd UP Forecast | 16.06 |
| 1st UP Forecast | 11.88 |
| 1st DOWN Forecast | -0.04 |
| 2nd DOWN Forecast | -4.22 |
| 3rd DOWN Forecast | -8.4 |
| 4th DOWN Forecast | -15.16 |
111 Inc ( NASDAQ USA Symbol : YI )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
YI Business Profile
111, Inc. operates an integrated online and offline platform in the healthcare market in the People's Republic of China. It operates through two segments, B2B and B2C. The company sells medical and wellness products through online retail, and wholesale and retail pharmacies, as well as provides value-added services, such as online consultation services and e-prescription services to consumers. Its product portfolio comprises prescription and over-the counter drugs, such as western and traditional Chinese medicinal drugs; nutritional supplements, such as vitamins and dietary products; contact lenses; medical supplies and devices, including bandages and thermometers; and personal care products, such as skin care, birth control, and sexual wellness products; and baby products. The company also operates an online marketplace where third-party sellers can directly sell to pharmacies; provides online loan application services to the clients of 1 Drug Mall, including pharmacies and wholesalers; and digital contract sales organization and data services. As of December 31, 2020, it operated 13 offline retail pharmacies under the Yi Hao Pharmacy brand name in Guangzhou, Wuhan, Tianjin, and Kunshan. In addition, the company offers warehousing, logistics, procurement, research and development, and consulting services; and software development and information technology support services. It serves pharmacies, pharmaceutical companies and distributors, medical professionals, and insurance companies. 111, Inc. has strategic partnerships with Bayer Healthcare Co. Ltd.; BeiGene, Ltd.; Jianming Pharmaceutical Group; and Chugai Pharma China Co., Ltd. The company was formerly known as New Peak Group and changed its name to 111, Inc. in April 2018. 111, Inc. was founded in 2010 and is headquartered in Shanghai, the People's Republic of China. Address: No. 295 ZuChongZhi Road, Shanghai, China, 201203
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service